Table 4.
Treatment and Relapses of Bloodstream Infections
| Organism | No. of Isolates | Treatment Continued Until Decannulation, No. (%) | Treatment Stopped Before Decannulation, No. (%) | Relapses, No. (%) | Relapses Off Antibiotics, No. (%) | Days to Relapse, Median (IQR) | Persistent Bloodstream Infections, No. (%) |
|---|---|---|---|---|---|---|---|
| Staphylococcus aureus | 26 | 16 (61.5) | 10 (38.5) | 4 (15.4) | 2 (7.7) | 30 (20–37) | 1 (3.8) |
| Enterococci | 34 | 8 (23.5) | 26 (76.5) | 9 (26.5) | 7 (20.1) | 25 (23–42) | 6 (17.6) |
| Coagulase-negative staphylococci | 6 | 1 (16.7) | 5 (83.3) | 2 (33.3) | 1 (16.7) | 23 (22–23) | 3 (50.0) |
| Other gram-positive organisms | 7 | 1 (14.3) | 6 (85.7) | 0 (0) | 0 (0) | N/A | 0 (0) |
| Pseudomonas aeruginosa | 5 | 2 (40.0) | 3 (60.0) | 2 (40.0) | 1 (20.0) | 18 (13–23) | 0 (0) |
| Other gram-negative bacilli | 32 | 13 (40.6) | 19 (59.4) | 8 (25.0) | 4 (12.5) | 21 (15–29) | 9 (28.1) |
| Candida | 13 | 7 (53.8) | 6 (46.2) | 4 (30.8) | 2 (15.4) | 24 (11–39) | 4 (30.8) |
Note. IQR, interquartile range.